The Epigenome and Methylation Clocks
DNA methylation as the most measurable layer of biological aging — and what it doesn't tell you.
What's covered
- T015mC, 5hmC, histone marks (H3K27me3, H3K4me3, H3K9me3, H3K27ac), chromatin accessibility
- T02First- vs second- vs third-generation methylation clocks (Horvath, Hannum → PhenoAge, GrimAge → DunedinPACE, CausAge)
- T03Tissue-of-origin and cell-composition deconvolution
- T04Reversibility: bariatric surgery, HCT, TRIIM, Yamanaka partial reprogramming
- T05Methylation-based diagnostics: Galleri, EpiSign for syndromic intellectual disability
- T06Histone code and chromatin therapies (EZH2, BET, HDAC, DOT1L)
By the end of this module you will be able to
- L01Explain what GrimAge predicts that Horvath's 2013 clock does not.
- L02Describe how DunedinPACE differs methodologically from epigenetic-age clocks and why pace-of-aging may be a more interventionally tractable endpoint.
- L03Counsel a patient about the limits of consumer methylation-age tests.
What you should walk away believing
- Epigenetic age is correlated with chronological age but explains additional all-cause mortality variance — most of it captured by GrimAge and DunedinPACE.
- Methylation clocks are sensitive to cell-composition shifts; whole-blood readouts confound 'aging' with immune-aging.
- Partial reprogramming with cyclic OSK can reset methylation age in vitro and in some mouse tissues; human clinical translation is preclinical (Altos, Retro Bio, NewLimit).
- EpiSign-style methylation profiling has become a clinical-grade diagnostic for >100 syndromic intellectual-disability disorders that were previously diagnostic dead-ends.
What this means at your level
The epigenome is the layer of chemical marks on DNA and histones that controls which genes are expressed without changing the sequence. DNA methylation — addition of a methyl group to cytosine — is the most measurable mark, and patterns of methylation correlate strongly with biological age, environmental exposures, and disease risk.
Methylation testing has two clinically validated uses today: (1) syndromic-disease diagnosis via episignatures (EpiSign covers >100 disorders); (2) cancer detection and tissue-of-origin (Galleri, methylation-based CNS tumor classifier). Consumer methylation-age tests (Elysium Index, TruDiagnostic, MyDNAge) are research-grade — useful for cohort tracking, weak for individual decisions.
Third-generation clocks (DunedinPACE) measure pace rather than age and show stronger response to interventions in the few RCTs to date (CALERIE caloric-restriction subcohort: ~2–3% slowdown). The CausAge clock (Ying et al. 2024) attempts to filter for causally-anchored CpGs to make the clock more interventionally meaningful.
Lowering my methylation age reverses biological aging.
A change in a clock readout is not the same as a change in mortality risk. Most clocks were trained to predict chronological age or specific outcomes, not validated as intervention-response biomarkers. Horvath himself has warned against treating clock-age as a target.
What the data say
Test yourself
Key terms & abbreviations
- 5mC
- 5-methylcytosine — the dominant DNA methylation mark in mammals, mostly at CpG dinucleotides.
- Episignature
- Disease-specific genome-wide methylation pattern used as a diagnostic biomarker for syndromic conditions.
- OSK / OSKM
- Oct4, Sox2, Klf4 (± c-Myc) — Yamanaka factors; partial cyclic expression can reset epigenetic marks without inducing pluripotency.
- Methylation clock
- Statistical model predicting chronological or biological age from DNA methylation values at a curated set of CpG sites.
Anchor references
- DNA methylation GrimAge strongly predicts lifespan and healthspan — Lu et al., Aging 2019
- DunedinPACE, a DNA methylation biomarker of the pace of aging — Belsky et al., eLife 2022